We are live on ! Find out more
IIM

Illumine Investment Management Portfolio holdings

AUM $154M
1-Year Est. Return 52.22%
This Fund
S&P 500
This Quarter Est. Return
+11.64%
1 Year Est. Return
+52.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$3.6M
Cap. Flow
-$6.53M
Cap. Flow %
-5.19%
Top 10 Hldgs %
31.74%
Holding
95
New
5
Increased
56
Reduced
10
Closed
8

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.25M
2
ZM icon
Zoom
ZM
+$1.81M
3
DT icon
Dynatrace
DT
+$1.58M
4
CDNS icon
Cadence Design Systems
CDNS
+$1.58M
5
ITRI icon
Itron
ITRI
+$757K

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Healthcare 15.21%
3 Financials 14.72%
4 Industrials 11.01%
5 Consumer Discretionary 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$81.9B
$1.7M 1.36%
3,245
+139
+4% +$77.6K
AME icon
27
Ametek
AME
$59B
$1.63M 1.3%
9,000
+127
+1% +$21.8K
ALL icon
28
Allstate
ALL
$66.3B
$1.59M 1.26%
+7,897
New +$1.58M
RLY icon
29
State Street Multi-Asset Real Return ETF
RLY
$1.31B
$1.53M 1.22%
52,656
+715
+1% +$20.3K
AOS icon
30
A.O. Smith
AOS
$8.5B
$1.51M 1.2%
+23,033
New +$1.51M
POWL icon
31
Powell Industries
POWL
$7.78B
$1.5M 1.19%
21,399
+438
+2% +$26.4K
QQQ icon
32
Invesco QQQ Trust
QQQ
$482B
$1.49M 1.19%
2,705
+2
+0.1% +$995
GNTX icon
33
Gentex
GNTX
$4.95B
$1.43M 1.14%
65,061
+1,676
+3% +$36.6K
LMND icon
34
Lemonade
LMND
$4.11B
$1.38M 1.1%
31,549
+1,071
+4% +$35.7K
DBEF icon
35
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.43B
$1.34M 1.07%
30,642
+690
+2% +$29.9K
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.1B
$1.24M 0.99%
9,879
+238
+2% +$27.3K
LMAT icon
37
LeMaitre Vascular
LMAT
$1.85B
$1.15M 0.91%
13,837
+321
+2% +$26.8K
TSM icon
38
TSMC
TSM
$2.23T
$1.14M 0.91%
5,046
JQUA icon
39
JPMorgan US Quality Factor ETF
JQUA
$8.58B
$1.06M 0.85%
17,720
-474
-3% -$27.1K
FN icon
40
Fabrinet
FN
$20.5B
$1.02M 0.81%
3,461
MPTI icon
41
M-tron Industries
MPTI
$382M
$1.02M 0.81%
24,266
+272
+1% +$13.1K
JPM icon
42
JPMorgan Chase
JPM
$967B
$998K 0.79%
3,441
CORT icon
43
Corcept Therapeutics
CORT
$12.1B
$961K 0.76%
13,093
+673
+5% +$48.8K
GOOGL icon
44
Alphabet (Google) Class A
GOOGL
$4.2T
$898K 0.71%
5,094
+24
+0.5% +$3.93K
FIX icon
45
Comfort Systems
FIX
$62B
$889K 0.71%
1,657
+12
+0.7% +$5.23K
AYI icon
46
Acuity Brands
AYI
$10.7B
$847K 0.67%
2,839
+68
+2% +$17.6K
ACMR icon
47
ACM Research
ACMR
$5.8B
$825K 0.66%
31,848
+586
+2% +$13.2K
URI icon
48
United Rentals
URI
$70.9B
$811K 0.65%
1,076
ESE icon
49
ESCO Technologies
ESE
$7.77B
$781K 0.62%
4,071
+22
+0.5% +$3.76K
RACE icon
50
Ferrari
RACE
$71.5B
$758K 0.6%
1,544

Similar funds

Illumine Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Illumine Investment Management held 95 positions worth $126M, up 2.9% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Illumine Investment Management withdrew a net $6.53M in Q2 2025, closing 8 positions and reducing 10 holdings. Its most notable exit was Apple, an estimated $5.25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Illumine Investment Management opened a new position in Allstate worth $1.59M.

  • Illumine Investment Management's largest Q2 2025 buy was Allstate: 7,897 shares worth $1.59M.
  • Illumine Investment Management added most to Regeneron Pharmaceuticals in Q2 2025, an estimated $77.6K increase.
  • Illumine Investment Management's biggest Q2 2025 reduction was Grayscale Bitcoin Trust, cutting an estimated $62.8K.
  • Illumine Investment Management fully exited Apple in Q2 2025, selling an estimated $5.25M.
  • Illumine Investment Management's ten largest holdings make up 32% of its $126M portfolio in Q2 2025.
  • Illumine Investment Management opened 5 new positions and closed 8 in Q2 2025.
  • Illumine Investment Management's portfolio value rose 2.9% quarter-over-quarter to $126M.

Based on Illumine Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.